Urgency and necessity of Epstein-Barr virus prophylactic vaccines
Abstract Epstein-Barr virus (EBV), a γ-herpesvirus, is the first identified oncogenic virus,
which establishes permanent infection in humans. EBV causes infectious mononucleosis …
which establishes permanent infection in humans. EBV causes infectious mononucleosis …
Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
W Li, X Duan, X Chen, M Zhan, H Peng… - Frontiers in …, 2023 - frontiersin.org
Epstein–Barr virus (EBV) was the first tumor virus in humans. Nasopharyngeal carcinoma
(NPC) accounts for approximately 60% of the 200,000 new tumor cases caused by EBV …
(NPC) accounts for approximately 60% of the 200,000 new tumor cases caused by EBV …
A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV
Epstein-Barr virus (EBV) is a global public health concern, as it is known to cause multiple
diseases while also being etiologically associated with a wide range of epithelial and …
diseases while also being etiologically associated with a wide range of epithelial and …
Affinity exploration of SARS-CoV-2 RBD variants to mAb-functionalized plasmonic metasurfaces for label-free immunoassay boosting
Plasmonic metasurfaces (PMs) functionalized with the monoclonal antibody (mAb) are
promising biophotonic sensors for biomolecular interaction analysis and convenient …
promising biophotonic sensors for biomolecular interaction analysis and convenient …
Targeting herpesvirus entry complex and fusogen glycoproteins with prophylactic and therapeutic agents
L Zhong, W Zhang, C Krummenacher, Y Chen… - Trends in …, 2023 - cell.com
Herpesviruses are among the most successful viruses found in human populations. They
establish lifelong latent infections, which are punctuated by recurrent reactivations. The entry …
establish lifelong latent infections, which are punctuated by recurrent reactivations. The entry …
Anti‐EBV antibodies: Roles in diagnosis, pathogenesis, and antiviral therapy
C Xie, LY Zhong, GL Bu, GX Zhao… - Journal of Medical …, 2023 - Wiley Online Library
Epstein‐Barr virus (EBV) infection is prevalent in global population and associated with
multiple malignancies and autoimmune diseases. During the infection, EBV‐harbored or …
multiple malignancies and autoimmune diseases. During the infection, EBV‐harbored or …
Epstein-Barr virus gp42 antibodies reveal sites of vulnerability for receptor binding and fusion to B cells
Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with B cell
lymphomas. EBV glycoprotein 42 (gp42) binds HLA class II and activates membrane fusion …
lymphomas. EBV glycoprotein 42 (gp42) binds HLA class II and activates membrane fusion …
Antibody and Cell-Based Therapies against Virus-Induced Cancers in the Context of HIV/AIDS
J Joseph, G Sandel, R Kulkarni, R Alatrash, BB Herrera… - Pathogens, 2023 - mdpi.com
Infectious agents, notably viruses, can cause or increase the risk of cancer occurrences.
These agents often disrupt normal cellular functions, promote uncontrolled proliferation and …
These agents often disrupt normal cellular functions, promote uncontrolled proliferation and …
Structures of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus virions reveal species-specific tegument and envelope features
J Zhen, J Chen, H Huang, S Liao, S Liu, Y Yuan… - Journal of …, 2024 - journals.asm.org
Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) are
classified into the gammaherpesvirus subfamily of Herpesviridae, which stands out from its …
classified into the gammaherpesvirus subfamily of Herpesviridae, which stands out from its …
Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infection
Epstein-Barr virus (EBV) is closely associated with cancer, multiple sclerosis, and post-acute
coronavirus disease 2019 (COVID-19) sequelae. There are currently no approved …
coronavirus disease 2019 (COVID-19) sequelae. There are currently no approved …